Lenacapavir

11 Results / Page 1 of 2

Oshiwambo

Uuministeli wuuhaku ouli moshikumungu shoku eta moshilongo owenda yoku keelela o HIV uulethimbo yo lenacapavir

Uuministeli wuuhaku owa tseyitha eshangitho lyuudha lyo Lenacapavir,oshingangamithi shoku keelela o HIV  uulethimbo,oku shangithwa moshilongo. Uuministeli wuuhaku owa kutha etokolo enene oku kondjitha o HIV ,paku endeleleka eshangitho lyo Lenacapavir,owenda hayi gandjwa lwaali momumvo,noku holola eitulemo lya Namibia kiilongomwa iipe nuuthikepamwe wuundjolowele. Zambia na South Africa oya shangitha nale owenda ndjoka tayi pingenapo o PrEP,noku tula Namibia mokati kiilongo iishona ya Africa oku shangitha uuteginology keelelo mbuka wepupi lya landulako. […]

today29 January, 2026

Oshiwambo

South Africa,Eswatini na Zambia ohela oya tameke okugandja owenda yo HIV ndjoka kwiitaala tayi keelele o HIV

South Africa,Eswatini na Zambia ohela oya tameke okugandja owenda yo HIV ndjoka kwiitaala tayi keelele o HIV,tayi gandjwa oshikando shotango mu Africa,ngoka ena omutenge omudhigu go HIV. O Lenacapavir,hayi gandjwa lwaali momumvo oyuulike tayi shonopeke etandeelo lyo HIV noo % dha konda 99.9,nokwa talikako tayi longo. Mo South Africa,moka omukuluntu gumwe yomuya 5 ena ombuto yo HIV,oshikondo shomapekapeko mo Wits University osha taalele etulomiilonga onga oshitopolwa shosheetwapo sha pewa eyambidhidho […]

today2 December, 2025

Oshiwambo

Zambia aninga oshilongo oshi 2 mu Africa ,oku longifa ovenda ipe yotunila yepango lo HIV

Epangelo la Zambia,  ola dimina elongifo lovenda ipe yo  Lenacapavir, ovenda oyo taika yandja ekwafo kovanhu ta valumbu noudu wo mbuto yo HIV noveli kepango lo ARV. Ediminino la Zambia, oku longifa ovenda ayo ola talika lili eenghendabala domupondo oku kondjifa oudu wo  HIV/AIDS moshilongo. Minister wouhaku moshilongo   Elijah Muchima, metitano ladjako okwati etulomoilonga lovenda ayo,  olili edidiliko langhene epangelo lelitulamo moku xulifapo oudu wombuto yo HIV mokati koshiwana okufika […]

today10 November, 2025

Oshiwambo

South Africa okwa ningi oshilongo shotango sha Africa oku zimina o Lenacapavir,LEN,owenda hayi gandjwa konima yoomwedhi hamano ,oku keelela iipotha yo HIV

  Ondohotola yuunamiti Dr Benard Haufiku okwati shiikwatelela komapekapeko,o LEN oyuulika tayi longo oku keelela etandeelo lyo HIV okuza momuntu ena ombuto okuya momuntu omukwawo. Dr Bernard Haufiku okwati owenda otayi ka kwathela ekeelelelo lyiipotha iipe yo HIV,ashike okwa londodha kutya,ngele  Namibia okwa mono ompito yowenda ndjoka,ati oyina ondilo ,,aantu oyendji oya pumbwa oku konakonwa,noku tseya mpoka ya thikama,opo nee taya tulwa kepango lyomondjila.

today28 October, 2025

Oshiwambo

UUministeli wuuhaku ouna omukumo mowenda yoku keelela o HIV yo lenacapavir

Uuministeli wuuhaku ouna omukumo kombinga yowenda yoku keelela o HIV o lenacapavir,ndjoka tayi ningilwa omalolelo miilongo ya Africa ya yooloka. Moshiluku shayo oshitiyali,owenda oyuulika iizemo tayi etitha oonkondo koohandimwe yena o HIV naamboka yaahena ombuto. Shiikwatelela ku Linda-Gail Bekker,omu Professor ko University of Cape town ,okwati omalolelo mo South Africa nomo Uganda oguulike kutya owenda tayigandjwa lwaali momumvo otayi gandja egameno lyuudha kyo HIV kaakiintu aagundjuka . Omalolelo oga yelekanitha […]

today17 October, 2024

Health / Medical

New HIV-AIDS Preventative Injection Shows Promising Results in African Trials

The Health ministry is optimistic about a new HIV-AIDS preventative injection, lenacapavir, currently undergoing trials in several African countries. In its second phase, the injection has shown promising results for both individuals living with HIV-AIDS and those uninfected. According to Linda-Gail Bekker, a professor at the University of Cape Town, trials in South Africa and Uganda indicate that a twice-yearly lenacapavir injection provides complete protection against HIV for young women. […]

today17 October, 2024

Health / Medical

Lenacapavir shows 96% HIV prevention success

A six-monthly HIV prevention injection containing lenacapavir has been confirmed effective in two pivotal studies. The first study, PURPOSE 1, showed no HIV infections among two-thousand-134 participants, while the second, PURPOSE 2, reported two infections among two-thousand-179 participants. This translates to a 96-percent reduction in HIV infections compared to background incidence. Gilead Sciences plans to file for regulatory approval to market lenacapavir for prevention. Separately, during a press briefing on Monday, the U.S. Department […]

today15 October, 2024

Oshiwambo

Owenda yoshingangamithi sho lenacapavir otayi vulu oku keelela o HIV

Owenda yoku keelela o HIV yoomwedhi 6 yina o lenacapavir oya kolekwa tayi longo ,momalolelo gopaali ga simana. Omapekapeko gotango,go Purpose1 oguulike pwaahena iipotha yo HIV maakuthimbinga 2 134,omanga omatiyali go PURPOSE 2,ga lopota iipotha 2 maakuthimbinga 2 179. Shika osha kalelapo eshonopeko lyoo % 96 lyiipotha yo HIV ,okuyeleka kiiniingwanima ya tetekele. O Gilead Sciences oya thaneka oku konga eziminino okuyela o lenacapavir oku keelela o HIV.  

today15 October, 2024

Oshiwambo

Otapa ningwa omalolelo gowenda tayi gandjwa lwaali momumvo okugamena aakiintu aagundjuka ko HIV

Omalolelo omanene ga ningwa mo South Africa nomo Uganda oguulike kutya owenda tayi gandjwa lwaali momvula otayi vulu okupa aakiintu aagundjuka egameno lyoo % 100 ko HIV. O SABC oya lopota kutya omalolelo otaga kongo oku tala ngele owenda yoomwedhi 6 yo lenacapavir otayi vulu okugandja egameno hwepo shi vulithe kiingangamithi yilwe yopaali,oopela hadhi nuwa lwaali mesiku ano o PrEP. Ospan yomapekapeko gopaunamiti okuza ko University of Cape town oya […]

today25 July, 2024